Title

"tech2go." Enterix of Falmouth says the new federal reimbursement rate for prod

Authors

Taylor Smith

Source

Mainebiz

Date

3-3-2003

Pages

20-21

Abstract

"tech2go." Enterix of Falmouth says the new federal reimbursement rate for production of its InSure colorectal cancer screening device will kill the company. The test is accurate, affordable, and, unlike its competitors, easy to use. Colorectal cancer, the second-leading cause of cancer-related deaths, is very curable when caught early. Convincing the Medicare bureaucracy causing the problem is an ongoing struggle. Details.

Subjects

Biotechnology industries, Cancer, Enterix Inc Falmouth

Full text is not available here. Please contact the Library for a copy of the article.

Share

COinS